title: Inhibition of Friend murine leukemia virus activity by guanosine/thymidine oligonucleotides.
abstract: Oligonucleotides consisting of only deoxyguanosine and deoxythymidine were stable in culture and were able to significantly inhibit Friend Murine Leukemia Virus (FMLV) production in acute cell culture assay systems. The oligonucleotides did not share homology with, or possess any complementary (antisense) sequence motifs to the FMLV genome. The guanosine/thymidine-containing oligonucleotides (GTOs) which demonstrated anti-FMLV activity in acute infection assays were synthesized with natural phosphodiester (PD) linkages (backbones). The observed antiviral activities of these oligonucleotides increased significantly when the PD backbone was replaced with a phosphorothioate (PT) backbone. Experiments designed to investigate a potential antiviral mechanism of action demonstrated that oligonucleotides tested were capable of blocking virus adsorption. In addition, GTOs with PD backbones were competitive inhibitors of FMLV reverse transcriptase (RT). When the same experiments were performed using oligonucleotides with PT backbones, all compounds tested demonstrated significant competitive inhibition of FMLV RT. The measured inhibitory activity of all compounds tested in culture assays was enhanced by at least a factor of 10 when the PD linkages were replaced with PT. The enhanced antiviral activity exhibited by the sulfur group on the oligonucleotide backbone, and the lack of any designed, sequence-specific interactions, suggest that a large percentage of the reported antiviral activity of oligonucleotides containing a phosphorothioate backbone is due to factors other than rationally designed, sequence-specific interactions. The ability of GTOs to inhibit FMLV in culture, potentially via a number of different mechanisms, makes this a class of compounds which warrants investigation as therapeutic agents to be used against retroviral infections.
authors.affiliation: Triplex Pharmaceutical Corporation, The Woodlands, TX 77380.
authors.forename: J
authors.initials: J
authors.lastname: Ojwang
authors.forename: K M
authors.initials: KM
authors.lastname: Okleberry
authors.forename: H B
authors.initials: HB
authors.lastname: Marshall
authors.forename: H M
authors.initials: HM
authors.lastname: Vu
authors.forename: J H
authors.initials: JH
authors.lastname: Huffman
authors.forename: R F
authors.initials: RF
authors.lastname: Rando
mesh_terms: D016475:3T3 Cells; D000818:Animals; D000998:Antiviral Agents / Q000138:chemical synthesis / Q000494:pharmacology*; D001483:Base Sequence; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D002851:Chromatography, High Pressure Liquid; D003849:Deoxyguanosine / Q000494:pharmacology*; D005622:Friend murine leukemia virus / Q000187:drug effects* / Q000502:physiology; D006367:HeLa Cells; D006801:Humans; D007124:Immunoenzyme Techniques; D051379:Mice; D008969:Molecular Sequence Data; D009838:Oligodeoxyribonucleotides / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D010957:Plasmids; D018894:Reverse Transcriptase Inhibitors; D013936:Thymidine / Q000494:pharmacology*; D014764:Viral Proteins / Q000032:analysis
chemical_list: D000998:Antiviral Agents; D009838:Oligodeoxyribonucleotides; D018894:Reverse Transcriptase Inhibitors; D014764:Viral Proteins; D003849:Deoxyguanosine; D013936:Thymidine